Assenagon Asset Management S.A. Has $37.65 Million Stake in Xylem Inc. $XYL

Assenagon Asset Management S.A. lowered its holdings in shares of Xylem Inc. (NYSE:XYLFree Report) by 33.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 276,496 shares of the industrial products company’s stock after selling 137,623 shares during the quarter. Assenagon Asset Management S.A. owned 0.11% of Xylem worth $37,653,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Ferguson Wellman Capital Management Inc. acquired a new stake in shares of Xylem during the third quarter worth $1,148,000. Vanguard Personalized Indexing Management LLC boosted its position in shares of Xylem by 19.0% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 56,216 shares of the industrial products company’s stock valued at $8,292,000 after acquiring an additional 8,960 shares during the period. XXEC Inc. grew its stake in shares of Xylem by 66.0% in the second quarter. XXEC Inc. now owns 33,698 shares of the industrial products company’s stock valued at $4,359,000 after acquiring an additional 13,404 shares in the last quarter. Covea Finance increased its position in Xylem by 25.5% during the third quarter. Covea Finance now owns 231,547 shares of the industrial products company’s stock worth $34,153,000 after acquiring an additional 47,000 shares during the period. Finally, AEGON ASSET MANAGEMENT UK Plc increased its position in Xylem by 9.8% during the third quarter. AEGON ASSET MANAGEMENT UK Plc now owns 417,651 shares of the industrial products company’s stock worth $61,629,000 after acquiring an additional 37,189 shares during the period. Institutional investors own 87.96% of the company’s stock.

Xylem Trading Up 1.1%

Shares of Xylem stock opened at $121.74 on Thursday. The company has a quick ratio of 1.28, a current ratio of 1.62 and a debt-to-equity ratio of 0.12. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $154.27. The company has a market capitalization of $29.60 billion, a price-to-earnings ratio of 31.05, a PEG ratio of 1.72 and a beta of 1.17. The firm’s 50-day moving average price is $130.89 and its two-hundred day moving average price is $138.70.

Xylem (NYSE:XYLGet Free Report) last issued its earnings results on Tuesday, February 10th. The industrial products company reported $1.42 EPS for the quarter, meeting the consensus estimate of $1.42. Xylem had a net margin of 10.59% and a return on equity of 11.11%. During the same period in the previous year, the firm posted $1.18 earnings per share. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. On average, analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem announced that its Board of Directors has authorized a share buyback plan on Wednesday, February 25th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

Xylem Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 24th. Shareholders of record on Tuesday, February 24th were given a dividend of $0.43 per share. This is an increase from Xylem’s previous quarterly dividend of $0.40. This represents a $1.72 annualized dividend and a yield of 1.4%. The ex-dividend date was Tuesday, February 24th. Xylem’s dividend payout ratio (DPR) is presently 43.88%.

Wall Street Analysts Forecast Growth

XYL has been the subject of a number of recent research reports. Barclays cut their price objective on shares of Xylem from $166.00 to $156.00 and set an “overweight” rating for the company in a report on Wednesday, February 11th. The Goldman Sachs Group set a $158.00 target price on shares of Xylem in a report on Wednesday, February 11th. Robert W. Baird set a $161.00 price target on Xylem in a research note on Wednesday, February 11th. Weiss Ratings reissued a “buy (b-)” rating on shares of Xylem in a research report on Monday, December 29th. Finally, William Blair initiated coverage on Xylem in a research note on Monday, January 26th. They set an “outperform” rating on the stock. Nine equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $158.08.

View Our Latest Analysis on Xylem

About Xylem

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.